A citation-based method for searching scientific literature

Jacob McGee, Vasily Giannakeas, Beth Karlan, Jan Lubinski, Jacek Gronwald, Barry Rosen, John McLaughlin, Harvey Risch, Ping Sun, William D Foulkes, Susan L Neuhausen, Joanne Kotsopoulos, Steven A Narod. Gynecol Oncol 2017
Times Cited: 21







List of co-cited articles
75 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.
Susan M Domchek, Komal Jhaveri, Sujata Patil, Jill E Stopfer, Clifford Hudis, Jacquelyn Powers, Zsofia Stadler, Laura Goldstein, Noah Kauff, Mustafa Khasraw,[...]. Cancer 2013
34
52

Breast cancer following ovarian cancer in BRCA mutation carriers.
Alexandra Gangi, Ilana Cass, Daniel Paik, Galinos Barmparas, Beth Karlan, Catherine Dang, Andrew Li, Christine Walsh, Bobbie J Rimel, Farin F Amersi. JAMA Surg 2014
26
47

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
994
42

The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
Peggy M L H Vencken, Mieke Kriege, Maartje Hooning, Marian B Menke-Pluymers, Bernadette A M Heemskerk-Gerritsen, Lena C van Doorn, Margriet M Collée, Agnes Jager, Cees van Montfort, Curt W Burger,[...]. Cancer 2013
20
40

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
724
23

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
J Boyd, Y Sonoda, M G Federici, F Bogomolniy, E Rhei, D L Maresco, P E Saigo, L A Almadrones, R R Barakat, C L Brown,[...]. JAMA 2000
384
23

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
520
19


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
872
19

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
19

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
529
14


Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.
Francisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Melissa C Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington, Susan J Ramus,[...]. Clin Cancer Res 2015
98
14


Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
637
14

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
163
14

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
719
14

Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis.
Qian Zhong, Hong-Ling Peng, Xia Zhao, Lin Zhang, Wei-Ting Hwang. Clin Cancer Res 2015
114
14

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
250
14


The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
Kelly A Metcalfe, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Ivo A Olivotto, William D Foulkes, Ellen Warner, Olufunmilayo Olopade, Andrea Eisen, Barbara Weber,[...]. Gynecol Oncol 2005
109
14

Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.
Alexander Olawaiye, Lori Caesar, Debra Walsh, Mollie Lyman, John Yeh, Kerry Rodabaugh, David Marchetti, Shashikant Lele, Kunle Odunsi. Gynecol Oncol 2004
13
23

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
978
14


Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women.
D Gareth Evans, Julie Wisely, Tara Clancy, Fiona Lalloo, Mary Wilson, Richard Johnson, Jonathon Duncan, Lester Barr, Ashu Gandhi, Anthony Howell. Breast Cancer Res 2015
56
9

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
384
9

The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
Lynn C Hartmann, Noralane M Lindor. N Engl J Med 2016
157
9

Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.
Joanne Kotsopoulos, Barry Rosen, Isabel Fan, Joel Moody, John R McLaughlin, Harvey Risch, Taymaa May, Ping Sun, Steven A Narod. Gynecol Oncol 2016
61
9

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
362
9

Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Kasmintan A Schrader, Jane Hurlburt, Steve E Kalloger, Samantha Hansford, Sean Young, David G Huntsman, C Blake Gilks, Jessica N McAlpine. Obstet Gynecol 2012
88
9

Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?
Joanne Kotsopoulos, Steven A Narod. Expert Rev Anticancer Ther 2018
3
66

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
9

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, Theresa Wagner, D Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Clin Breast Cancer 2007
56
9

Decision making for breast cancer prevention among women at elevated risk.
Tasleem J Padamsee, Celia E Wills, Lisa D Yee, Electra D Paskett. Breast Cancer Res 2017
33
9

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
Kandice K Ludwig, Joan Neuner, Annabelle Butler, Jennifer L Geurts, Amanda L Kong. Am J Surg 2016
95
9

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
113
9

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
9

Metastatic breast cancer from gastric and ovarian cancer, mimicking inflammatory breast cancer: report of two cases.
Tomoi Sato, Ichiro Muto, Mae Fushiki, Miki Hasegawa, Masaki Hasegawa, Takeshi Sakai, Masao Sekiya. Breast Cancer 2008
31
9

Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review.
Rebecca L Klein, Amanda R Brown, Christian M Gomez-Castro, Setsuko K Chambers, Janiel M Cragun, Lauren Grasso-Lebeau, Julie E Lang. J Cancer 2010
38
9

Intramammary metastases: comparison of mammographic and ultrasound features.
Jasmin Abbas, Andreas Wienke, Rolf Peter Spielmann, Andreas Gunter Bach, Alexey Surov. Eur J Radiol 2013
17
11

Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
Monica A Recine, Michael T Deavers, Lavinia P Middleton, Elvio G Silva, Anais Malpica. Am J Surg Pathol 2004
79
9

Metastasis of ovarian cancer to the breast: A report of two cases and a review of the literature.
Clemens B Tempfer, Nariman El Fizazi, Hassan Ergonenc, Wiebke Solass. Oncol Lett 2016
15
13

Non-mammary metastases to the breast and axilla: a study of 85 cases.
Deborah F DeLair, Adriana D Corben, Jeffrey P Catalano, Christina E Vallejo, Edi Brogi, Lee K Tan. Mod Pathol 2013
73
9

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
A P M Heintz, F Odicino, P Maisonneuve, M A Quinn, J L Benedet, W T Creasman, H Y S Ngan, S Pecorelli, U Beller. Int J Gynaecol Obstet 2006
524
9

Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
Andrea E Wahner Hendrickson, Jamie N Bakkum-Gamez, Fergus J Couch, Karthik Ghosh, Judy C Boughey. Ann Surg Oncol 2017
2
100

Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Esther Molina-Montes, Marina Pollán, Tilman Payer, Elena Molina, Cristina Dávila-Arias, María-José Sánchez. Gynecol Oncol 2013
22
9

Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
Angela George, Stan Kaye, Susana Banerjee. Nat Rev Clin Oncol 2017
96
9

Managing hereditary breast cancer risk in women with and without ovarian cancer.
Mary Linton Peters, Judy E Garber, Nadine Tung. Gynecol Oncol 2017
8
25

Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study.
Kjell Bergfeldt, Bosse Rydh, Fredrik Granath, Henrik Grönberg, Lukman Thalib, Hans-Olov Adami, Per Hall. Lancet 2002
46
9

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.
Kelsey E Lewis, Karen H Lu, Amber M Klimczak, Samuel C Mok. Cancers (Basel) 2018
14
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.